QNRX vs SOFI · $9.6M cap vs P/E 39, rev $283.1M
Quoin Pharmaceuticals Ltd DRC (QNRX) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Quoin Pharmaceuticals Ltd DRC (QNRX) is a biotechnology company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ. It is led by Anthony J. Noto.
QNRX does not have a complete income-statement cache yet.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
QNRX currently screens at market cap $9.6M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the QNRX and SOFI stock pages for the full models.
Not investment advice.